Rectal Mesalazine - Global and China Top Players Market Share and Ranking 2023
This report studies and analyses global Rectal Mesalazine status and future trends, to help determine the Rectal Mesalazine market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Rectal Mesalazine, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Rectal Mesalazine market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Rectal Mesalazine by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Rectal Mesalazine by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Rectal Mesalazine key consuming regions, consumption value and demand structure
(5) Rectal Mesalazine industry chains, upstream, midstream and downstream
According to YH Research, the global market for Rectal Mesalazine should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China's market share increased from percent to percent. China Rectal Mesalazine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Rectal Mesalazine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Ulcerative Colitis grew percent to account for percent of the total market sales, and Crohn's Disease grew percent.
Market segment by players, this report covers
Ferring Global
AbbVie
Reid-Rowell
Dr. Falk Pharma UK
Alaven Pharmaceutical
Market segment by Type, covers
Suppository
Enema
Market segment by Application, can be divided into
Ulcerative Colitis
Crohn's Disease
Inflammatory Bowel Disease
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Rectal Mesalazine product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Rectal Mesalazine market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Rectal Mesalazine market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Rectal Mesalazine industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
1 Market Overview
1.1 Rectal Mesalazine Definition
1.2 Global Rectal Mesalazine Market Size and Forecast
1.3 China Rectal Mesalazine Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Rectal Mesalazine Market Size: China VS Global Growth Rate, 2018-2029
1.6 Rectal Mesalazine Market Dynamics
1.6.1 Rectal Mesalazine Market Drivers
1.6.2 Rectal Mesalazine Market Restraints
1.6.3 Rectal Mesalazine Industry Trends
1.6.4 Rectal Mesalazine Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Rectal Mesalazine, Global Market Share by Company, 2018-2023
2.2 Global Rectal Mesalazine Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Rectal Mesalazine Concentration Ratio
2.4 Global Rectal Mesalazine Mergers & Acquisitions, Expansion Plans
2.5 Global Rectal Mesalazine Major Companies Product Type
2.6 Head Office and Rectal Mesalazine Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Rectal Mesalazine, China Market Share by Company, 2018-2023
3.2 China Rectal Mesalazine Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Rectal Mesalazine Industry Chain
4.2 Rectal Mesalazine Upstream Analysis
4.2.1 Rectal Mesalazine Core Raw Materials
4.2.2 Main Manufacturers of Rectal Mesalazine Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Rectal Mesalazine Production Mode
4.6 Rectal Mesalazine Procurement Model
4.7 Rectal Mesalazine Industry Sales Model and Sales Channels
4.7.1 Rectal Mesalazine Sales Model
4.7.2 Rectal Mesalazine Typical Distributors
5 Sights by Type
5.1 Rectal Mesalazine Classification
5.1.1 Suppository
5.1.2 Enema
5.2 By Type, Global Rectal Mesalazine Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Rectal Mesalazine Consumption Value, 2018-2029
6 Sights by Application
6.1 Rectal Mesalazine Segment by Application
6.1.1 Ulcerative Colitis
6.1.2 Crohn's Disease
6.1.3 Inflammatory Bowel Disease
6.2 By Application, Global Rectal Mesalazine Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Rectal Mesalazine Consumption Value, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Rectal Mesalazine Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Rectal Mesalazine Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Rectal Mesalazine & Forecasts, 2018-2029
7.3.2 By Country, North America Rectal Mesalazine Market Size Market Share
7.4 Europe
7.4.1 Europe Rectal Mesalazine Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Rectal Mesalazine Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Rectal Mesalazine Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Rectal Mesalazine Market Size Market Share
7.6 South America
7.6.1 South America Rectal Mesalazine Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Rectal Mesalazine Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Rectal Mesalazine Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Rectal Mesalazine Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Rectal Mesalazine Market Size, 2018-2029
8.3.2 By Type, U.S. Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Rectal Mesalazine Market Size, 2018-2029
8.4.2 By Type, Europe Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
8.5 China
8.5.1 China Rectal Mesalazine Market Size, 2018-2029
8.5.2 By Type, China Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Rectal Mesalazine Market Size, 2018-2029
8.6.2 By Type, Japan Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Rectal Mesalazine Market Size, 2018-2029
8.7.2 By Type, South Korea Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Rectal Mesalazine Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Rectal Mesalazine Market Size, 2018-2029
8.9.2 By Type, India Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
8.10 Middle East & Africa
8.10.1 Middle East & Africa Rectal Mesalazine Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
9 Company Profile
9.1 Ferring Global
9.1.1 Ferring Global Company Information, Head Office, Market Area and Industry Position
9.1.2 Ferring Global Company Profile and Main Business
9.1.3 Ferring Global Rectal Mesalazine Models, Specifications and Application
9.1.4 Ferring Global Rectal Mesalazine Revenue and Gross Margin, 2018-2023
9.1.5 Ferring Global Recent Developments
9.2 AbbVie
9.2.1 AbbVie Company Information, Head Office, Market Area and Industry Position
9.2.2 AbbVie Company Profile and Main Business
9.2.3 AbbVie Rectal Mesalazine Models, Specifications and Application
9.2.4 AbbVie Rectal Mesalazine Revenue and Gross Margin, 2018-2023
9.2.5 AbbVie Recent Developments
9.3 Reid-Rowell
9.3.1 Reid-Rowell Company Information, Head Office, Market Area and Industry Position
9.3.2 Reid-Rowell Company Profile and Main Business
9.3.3 Reid-Rowell Rectal Mesalazine Models, Specifications and Application
9.3.4 Reid-Rowell Rectal Mesalazine Revenue and Gross Margin, 2018-2023
9.3.5 Reid-Rowell Recent Developments
9.4 Dr. Falk Pharma UK
9.4.1 Dr. Falk Pharma UK Company Information, Head Office, Market Area and Industry Position
9.4.2 Dr. Falk Pharma UK Company Profile and Main Business
9.4.3 Dr. Falk Pharma UK Rectal Mesalazine Models, Specifications and Application
9.4.4 Dr. Falk Pharma UK Rectal Mesalazine Revenue and Gross Margin, 2018-2023
9.4.5 Dr. Falk Pharma UK Recent Developments
9.5 Alaven Pharmaceutical
9.5.1 Alaven Pharmaceutical Company Information, Head Office, Market Area and Industry Position
9.5.2 Alaven Pharmaceutical Company Profile and Main Business
9.5.3 Alaven Pharmaceutical Rectal Mesalazine Models, Specifications and Application
9.5.4 Alaven Pharmaceutical Rectal Mesalazine Revenue and Gross Margin, 2018-2023
9.5.5 Alaven Pharmaceutical Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables and Figures
Table 1. Rectal Mesalazine Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Rectal Mesalazine Market Restraints
Table 3. Rectal Mesalazine Market Trends
Table 4. Rectal Mesalazine Industry Policy
Table 5. Global Rectal Mesalazine Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Rectal Mesalazine Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Rectal Mesalazine Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Rectal Mesalazine Mergers & Acquisitions, Expansion Plans
Table 9. Global Rectal Mesalazine Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Rectal Mesalazine Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 12. China Rectal Mesalazine Revenue Market Share by Company, 2018-2023
Table 13. Global Key Players of Rectal Mesalazine Upstream (Raw Materials)
Table 14. Global Rectal Mesalazine Typical Customers
Table 15. Rectal Mesalazine Typical Distributors
Table 16. By Type, Global Rectal Mesalazine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Application, Global Rectal Mesalazine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Rectal Mesalazine Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 19. By Region, Global Rectal Mesalazine Consumption Value, 2018-2029, US$ Million
Table 20. By Country, Global Rectal Mesalazine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 21. By Country, Global Rectal Mesalazine Consumption Value, 2018-2029, US$ Million
Table 22. By Country, Global Rectal Mesalazine Consumption Value Market Share, 2018-2029
Table 23. Ferring Global Company Information, Head Office, Market Area and Industry Position
Table 24. Ferring Global Company Profile and Main Business
Table 25. Ferring Global Rectal Mesalazine Models, Specifications, and Application
Table 26. Ferring Global Rectal Mesalazine Revenue and Gross Margin, US$ Million, 2018-2023
Table 27. Ferring Global Recent Developments
Table 28. AbbVie Company Information, Head Office, Market Area and Industry Position
Table 29. AbbVie Company Profile and Main Business
Table 30. AbbVie Rectal Mesalazine Models, Specifications, and Application
Table 31. AbbVie Rectal Mesalazine Revenue and Gross Margin, US$ Million, 2018-2023
Table 32. AbbVie Recent Developments
Table 33. Reid-Rowell Company Information, Head Office, Market Area and Industry Position
Table 34. Reid-Rowell Company Profile and Main Business
Table 35. Reid-Rowell Rectal Mesalazine Models, Specifications, and Application
Table 36. Reid-Rowell Rectal Mesalazine Revenue and Gross Margin, US$ Million, 2018-2023
Table 37. Reid-Rowell Recent Developments
Table 38. Dr. Falk Pharma UK Company Information, Head Office, Market Area and Industry Position
Table 39. Dr. Falk Pharma UK Company Profile and Main Business
Table 40. Dr. Falk Pharma UK Rectal Mesalazine Models, Specifications, and Application
Table 41. Dr. Falk Pharma UK Rectal Mesalazine Revenue and Gross Margin, US$ Million, 2018-2023
Table 42. Dr. Falk Pharma UK Recent Developments
Table 43. Alaven Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 44. Alaven Pharmaceutical Company Profile and Main Business
Table 45. Alaven Pharmaceutical Rectal Mesalazine Models, Specifications, and Application
Table 46. Alaven Pharmaceutical Rectal Mesalazine Revenue and Gross Margin, US$ Million, 2018-2023
Table 47. Alaven Pharmaceutical Recent Developments
List of Figures
Figure 1. Rectal Mesalazine Picture
Figure 2. Global Rectal Mesalazine Consumption Value, (US$ million) & (2018-2029)
Figure 3. China Rectal Mesalazine Consumption Value, (US$ million) & (2018-2029)
Figure 4. By Consumption Value, China Rectal Mesalazine Market Share of Global, 2018-2029
Figure 5. Global Rectal Mesalazine Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 6. China Rectal Mesalazine Key Participants, Market Share, 2022
Figure 7. Rectal Mesalazine Industry Chain
Figure 8. Rectal Mesalazine Procurement Model
Figure 9. Rectal Mesalazine Sales Model
Figure 10. Rectal Mesalazine Sales Channels, Direct Sales, and Distribution
Figure 11. Suppository
Figure 12. Enema
Figure 13. By Type, Global Rectal Mesalazine Consumption Value, 2018-2029, US$ Million
Figure 14. By Type, Global Rectal Mesalazine Consumption Value Market Share, 2018-2029
Figure 15. Ulcerative Colitis
Figure 16. Crohn's Disease
Figure 17. Inflammatory Bowel Disease
Figure 18. By Application, Global Rectal Mesalazine Consumption Value, 2018-2029, US$ Million
Figure 19. By Application, Global Rectal Mesalazine Consumption Value Market Share, 2018-2029
Figure 20. By Region, Global Rectal Mesalazine Consumption Value Market Share, 2018-2029
Figure 21. North America Rectal Mesalazine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 22. By Country, North America Rectal Mesalazine Consumption Value Market Share, 2022
Figure 23. Europe Rectal Mesalazine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, Europe Rectal Mesalazine Consumption Value Market Share, 2022
Figure 25. Asia Pacific Rectal Mesalazine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 26. By Country/Region, Asia Pacific Rectal Mesalazine Consumption Value Market Share, 2022
Figure 27. South America Rectal Mesalazine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 28. By Country, South America Rectal Mesalazine Consumption Value Market Share, 2022
Figure 29. Middle East & Africa Rectal Mesalazine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 30. U.S. Rectal Mesalazine Consumption Value, 2018-2029, US$ Million
Figure 31. By Type, U.S. Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
Figure 32. By Application, U.S. Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
Figure 33. Europe Rectal Mesalazine Consumption Value, 2018-2029, US$ Million
Figure 34. By Type, Europe Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
Figure 35. By Application, Europe Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
Figure 36. China Rectal Mesalazine Consumption Value, 2018-2029, US$ Million
Figure 37. By Type, China Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
Figure 38. By Application, China Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
Figure 39. Japan Rectal Mesalazine Consumption Value, 2018-2029, US$ Million
Figure 40. By Type, Japan Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
Figure 41. By Application, Japan Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
Figure 42. South Korea Rectal Mesalazine Consumption Value, 2018-2029, US$ Million
Figure 43. By Type, South Korea Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
Figure 44. By Application, South Korea Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
Figure 45. Southeast Asia Rectal Mesalazine Consumption Value, 2018-2029, US$ Million
Figure 46. By Type, Southeast Asia Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
Figure 47. By Application, Southeast Asia Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
Figure 48. India Rectal Mesalazine Consumption Value, 2018-2029, US$ Million
Figure 49. By Type, India Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
Figure 50. By Application, India Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
Figure 51. Middle East & Africa Rectal Mesalazine Consumption Value, 2018-2029, US$ Million
Figure 52. By Type, Middle East & Africa Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
Figure 53. By Application, Middle East & Africa Rectal Mesalazine Consumption Value Market Share, 2022 VS 2029
Figure 54. Research Methodology
Figure 55. Breakdown of Primary Interviews
Figure 56. Bottom-up and Top-down Approaches
Figure 57. Top-down Approaches
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets